The purpose of this study is to evaluate the safety and effectiveness of the ACURATE TAVR system in patient with severe aortic valve stenosis who are identified as an appropriate candidate for the TAVR procedure.

The purpose of this study is to define patient populations who may recover left atrial mechanical function rapidly (<24 hours) following cardioversion. Defining these characteristics will help us weigh the risks and benefits of anticoagulation following cardioversion.

The purpose of this study is to test the effectiveness of Vertex Pulmonary Embolectomy System in treating pulmonary embolisms

The purpose of this study is to collect data on patients with an elevated Lp(a) to identify patients for future drug studies.

There are multiple devices that have been developed and approved to help treat heart failure symptoms, yet some patients who qualify for these devices are denied authorization by their insurance. We look to describe trends across the United States.

This study is meant to test how effective the Laguna system is at treating pulmonary embolism.

A Phase IV, multicenter, randomized, open label trial to evaluate the effectiveness of inclisiran + usual care vs usual care alone as a tool to close care gaps within a pragmatic framework in an inclusive and underrepresented population at high risk for or diagnosed with ASCVD.

The purpose of this study is to assess the CAC score of PREVENTABLE patients.

This study is trying to understand whether ziltivekimab can help patients who have recently had a heart attack.

The purpose of this study is to determine if a new medication is effective at treating cardiac amyloidosis.